Chromatin texture features in hematoxylin and eosin-stained prostate tissue. 1993

R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
Department of Pathology and Cell Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107-5244.

A pilot study was undertaken to determine the expression of certain nuclear features in prostatic lesions. Twenty cases, 5 of hyperplasia and 5 each of carcinoma, Mostofi grades I-III, were selected as a training set, and an additional 20 cases were used as a test set, including 5 cases of hyperplasia and 5 cases each in Mostofi grades I-III. Images of hematoxylin and eosin-stained, 4-microns paraffin sections were obtained with a JVC BY-110 three-color camera and digitized by an IBM personal computer with a Matrox MVP-AT/NP imaging board. Thirty nuclei for each case from the training set, for a total of 600 nuclei, and 10 nuclei for each case from the test set, for a total of 200 nuclei, were analyzed by quantitative cytometric software on a SUN 3/60 workstation. A linear discriminant model was used for statistical analysis. One hundred percent of the hyperplasia group, 98% of the low grade group, 92% of the medium grade group and 82% of the high grade group were classified correctly in the test set with an overall success rate of 93%. Statistically significant chromatin texture features included heterogeneity, condensation, margination, run length nonuniformity, long run emphasis, gray level nonuniformity and inertia. Area, roundness and staining intensity (total extinction) were also significant. The results with standard hematoxylin and eosin-stained tissue sections were similar to those previously obtained with Feulgen-stained material. These results indicate that routine hematoxylin and eosin-stained material offers consistent diagnostic clues.

UI MeSH Term Description Entries
D007091 Image Processing, Computer-Assisted A technique of inputting two-dimensional or three-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. Biomedical Image Processing,Computer-Assisted Image Processing,Digital Image Processing,Image Analysis, Computer-Assisted,Image Reconstruction,Medical Image Processing,Analysis, Computer-Assisted Image,Computer-Assisted Image Analysis,Computer Assisted Image Analysis,Computer Assisted Image Processing,Computer-Assisted Image Analyses,Image Analyses, Computer-Assisted,Image Analysis, Computer Assisted,Image Processing, Biomedical,Image Processing, Computer Assisted,Image Processing, Digital,Image Processing, Medical,Image Processings, Medical,Image Reconstructions,Medical Image Processings,Processing, Biomedical Image,Processing, Digital Image,Processing, Medical Image,Processings, Digital Image,Processings, Medical Image,Reconstruction, Image,Reconstructions, Image
D008297 Male Males
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002843 Chromatin The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell. Chromatins
D004801 Eosine Yellowish-(YS) A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media. Eosin,Eosine Yellowish,Tetrabromofluorescein,Acid Red 87,C.I. Acid Red 87,Eosin (yellowish) (free acid),Eosin Y,Eosine,Eosine Yellowish-(YS), Dipotassium Salt,Eosine Yellowish-(YS), Potassium, Sodium Salt
D006416 Hematoxylin A dye obtained from the heartwood of logwood (Haematoxylon campechianum Linn., Leguminosae) used as a stain in microscopy and in the manufacture of ink. Hydroxybrazilin,Haematoxylon,Hematoxiline,Hemotoxylin,Hydroxybrasilin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
January 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology,
R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
August 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology,
R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
January 1988, Disease markers,
R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
November 2019, World journal of methodology,
R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
August 2012, The Journal of dermatology,
R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
November 2002, Journal of the American Academy of Dermatology,
R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
January 2010, Journal of biomedical optics,
R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
January 2014, Methods in molecular biology (Clifton, N.J.),
R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
January 2004, Toxicology mechanisms and methods,
R Christen, and J Xiao, and C Minimo, and G Gibbons, and B T Fitzpatrick, and H Galera-Davidson, and P H Bartels, and M Bibbo
January 1985, Sudebno-meditsinskaia ekspertiza,
Copied contents to your clipboard!